Cardiovascular Journal Publications
This page includes links to Lilly sponsored clinical trials that have been published in peer reviewed journals over the last 3 years. The list of publications below is limited to products that have been approved for use and may contain information about doses, delivery devices, uses, formulations and populations different from product labeling. Clinical decisions should be based on the full safety and efficacy information contained in the product's Full Prescribing Information in the provided link below.
If you have questions about a Lilly study not listed below or would like to request an electronic copy of one of the journal publications on this page, please Contact Lilly services below for further assistance.
Effient
Resource Utilization and Costs Associated With Percutaneous Coronary Intervention When Treating Patients With Acute Coronary Syndrome in the Mexican National Institute of Cardiology “Ignacio Chávez”
Published Date: August 13, 2019One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database
Published Date: December 11, 2017Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes
Published Date: March 10, 2017The Rationale for and Clinical Pharmacology of Prasugrel 5 mg
Published Date: March 9, 2017No Publications.
Novel findings from the multinational DOVE study on geographic and age‐related differences in pain perception and analgesic usage in children with sickle cell anaemia
Published Date: April 21, 2018Successful utilization of an electronic pain diary in a multinational phase 3 interventional study of pediatric sickle cell anemia
Published Date: July 26, 2017Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization
Published Date: June 1, 2017Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome
Published Date: May 31, 2017Relationship Between Peak Troponin Values and Long-Term Ischemic Events Among Medically Managed Patients With Acute Coronary Syndromes
Published Date: April 11, 2017Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes
Published Date: April 5, 2017Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome
Published Date: April 3, 2017A risk scoring system to predict coronary stent thrombosis
Published Date: March 9, 2017The Rationale for and Clinical Pharmacology of Prasugrel 5 mg
Published Date: March 9, 2017Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome
Published Date: February 21, 2017Prasugrel for Japanese patients with acute coronary syndrome in short-term clinical practice (PRASFIT-Practice I): a postmarketing observational study
Published Date: February 17, 2017Risk of bleeding and repeated bleeding events in prasugrel-treated patients: a review of data from the Japanese PRASFIT studies
Published Date: January 17, 2017One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database
Published Date: December 11, 2017Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Published Date: October 31, 2017The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: I nsights from the TRANSLATE-ACS study
Published Date: October 8, 2017Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study
Published Date: October 5, 2017Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction A Secondary Analysis of the TRANSLATE-ACS Study
Published Date: May 24, 2017Association of measured platelet reactivity with changes in P2Y 12 receptor inhibitor therapy and outcomes after myocardial infarction: Insights into routine clinical practice from the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study
Published Date: March 1, 2017Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study
Published Date: February 21, 2017Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational study
Published Date: January 20, 2017